RALPH AIKEN: Open Payments
NPI 1053502021 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,898 in 103 payments from 24 companies in 2025. Trend: 2023 $1,633 · 2024 $1,137 · 2025 $1,898
Food & beverage: $1,686Travel & lodging: $192Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $350 |
| Boston Scientific Corporation | 3 | $340 |
| PFIZER INC. | 16 | $249 |
| Novo Nordisk Inc | 9 | $139 |
| Exact Sciences Corporation | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Lilly USA, LLC | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
Products named: QULIPTA, WATCHMAN FLX, WATCHMAN, ELIQUIS, UBRELVY, NURTEC ODT, REXULTI, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
